Table 2 Characteristics of included trials
Study | Study design | Gender | Mean age | SBP (mm Hg), DBP (mm Hg), Pulse (beats/min) | Number of patients in Group 1 | Number of patients in Group 2 |
|---|---|---|---|---|---|---|
Appelboam et al. [2] | RCT | Group 1; (Male; n = 80, Female; n = 134), Group 2; (Male; n = 89, Female; n = 125) | Group 1; 54.5 (± 16.8), Group 2; 55.1 (± 16.3) | Group 1 (SBP; 124 (± 22), DBP; 82 (± 18)), pulse rate 179 (± 29), Group 2 (SBP; 125 (± 23), DBP; 83 (± 19)), pulse rate 172 (± 29) | 214 | 214 |
Çorbacıoğlu [5] 2017 | RCT | Group 1; (Male; n = 13, Female; n = 15), Group 2; (Male; n = 10, Female; n = 18) | Median (IQR) Group 1; 48.4 (40–60), Group 2; 44.3 (34–53.7) | Group 1 (SBP; 125.3 (115–137), DBP; 75.6 (64–86)) pulse rate 180 (160–195), Group 2 (SBP; 123.6 (100–144), DBP; 75.2 (60–88)) pulse rate 180 (160–201), | 28 | 28 |
Ceylan et al. [3] | RCT | Group 1; (Male; n = 14, Female; n = 19), Group 2; (Male; n = 17, Female; n = 15) | Median (IQR) Group 1; 61 (46–67), Group 2; 50(36–61) | Group 1 (SBP; 126 (113–138), DBP; 76 (71–89)) pulse rate 167 (147–187), Group 2 (SBP; 116 (106–136), DBP; 81 (73–89)), pulse rate 177 (165–192) | 33 | 32 |
Chen [4] 2019 | RCT | NA | NA | NA | 119 | 119 |